Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Driver
4.2 Challenges


5. Global Adult Vaccines Market


6. Market & Numbers Share – Adult Vaccines Analysis

6.1 Market Share
6.2 Population Share


7. Adult Vaccinated Numbers


8. Disease wise – Adult Vaccines Market

8.1 Coronavirus (COVID-19)
8.2 Influenza
8.3 Cervical Cancer (HPV)
8.4 Zoster (Shingles)
8.5 MMR (Measles, Mumps, and Rubella Vaccine)
8.6 Pneumococcal
8.7 Meningococcal
8.8 Hepatitis
8.9 TdaP
8.10 Travel and Miscellaneous
8.11 Varicella


9. Disease wise – Numbers of Adults Vaccinated

9.1 Coronavirus (COVID-19)
9.2 Influenza
9.3 Cervical Cancer (HPV)
9.4 Zoster (Shingles)
9.5 MMR
9.6 Pneumococcal
9.7 Meningococcal
9.8 Hepatitis
9.9 TdaP
9.10 Varicella


10. Mergers and Acquisitions in the Vaccine Industry


11. Vaccines and Regulator’s Interventions

11.1 Making and Meeting Standards of Quality and Safety
11.2 Vaccine Funding


12. Vaccines – Products and Pipeline

12.1 GSK Vaccine Product Pipeline
12.2 Merck Vaccine Product Pipeline
12.3 Sanofi Vaccine Product Pipeline
12.4 Pfizer Vaccine Product Pipeline


13. Porters Five Forces

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes


14. Key Players

14.1 GlaxoSmithKline, plc.’s

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Sales Analysis

14.2 Merck & Co.

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Sales Analysis

14.3 Sanofi Pasteur’s

14.3.1 Overview
14.3.2 Recent Development
14.3.3 Sales Analysis

14.4 Pfizer, Inc.’s

14.4.1 Overview
14.4.2 Recent Development
14.4.3 Sales Analysis

14.5 CSL Limited

14.5.1 Overview
14.5.2 Recent Development
14.5.3 Sales Analysis



List of Figures

Figure-01: Global Adult Vaccines Market (Billion US$), 2016 – 2021
Figure-02: Global – Forecast for Adult Vaccines Market (Billion US$), 2022 – 2027
Figure-03: Global – Adult Vaccines Number (Million), 2016 – 2021
Figure-04: Global – Forecast for Adult Vaccines Number (Million), 2022 – 2027
Figure-05: Disease wise – Influenza Market (Million US$), 2016 – 2021
Figure-06: Disease wise – Forecast for Influenza Market (Million US$), 2022 – 2027
Figure-07: Disease wise – Cervical Cancer (HPV) Market (Million US$), 2016 – 2021
Figure-08: Disease wise – Forecast for Cervical Cancer (HPV) Market (Million US$), 2022 – 2027
Figure-09: Disease wise – Zoster (Shingles) Market (Million US$), 2016 – 2021
Figure-10: Disease wise – Forecast for Zoster (Shingles) Market (Million US$), 2022 – 2027
Figure-11: Disease wise – MMR (Measles, Mumps, and Rubella Vaccine) Market (Million US$), 2016 – 2021
Figure-12: Disease wise – Forecast for MMR (Measles, Mumps, and Rubella Vaccine) Market (Million US$), 2022 – 2027
Figure-13: Disease wise – Pneumococcal Market (Million US$), 2016 – 2021
Figure-14: Disease wise – Forecast for Pneumococcal Market (Million US$), 2022 – 2027
Figure-15: Disease wise – Meningococcal Market (Million US$), 2016 – 2021
Figure-16: Disease wise – Forecast for Meningococcal Market (Million US$), 2022 – 2027
Figure-17: Disease wise – Hepatitis Market (Million US$), 2016 – 2021
Figure-18: Disease wise – Forecast for Hepatitis Market (Million US$), 2022 – 2027
Figure-19: Disease wise – TdaP Market (Million US$), 2016 – 2021
Figure-20: Disease wise – Forecast for TdaP Market (Million US$), 2022 – 2027
Figure-21: Disease wise – Travel and Miscellaneous Market (Million US$), 2016 – 2021
Figure-22: Disease wise – Forecast for Travel and Miscellaneous Market (Million US$), 2022 – 2027
Figure-23: Disease wise – Varicella Market (Million US$), 2016 – 2021
Figure-24: Disease wise – Forecast for Varicella Market (Million US$), 2022 – 2027
Figure-25: Disease wise – Influenza Number (Million), 2016 – 2021
Figure-26: Disease wise – Forecast for Influenza Number (Million), 2022 – 2027
Figure-27: Disease wise – Cervical Cancer (HPV) Number (Million), 2016 – 2021
Figure-28: Disease wise – Forecast for Cervical Cancer (HPV) Number (Million), 2022 – 2027
Figure-29: Disease wise – Zoster (Shingles) Number (Million), 2016 – 2021
Figure-30: Disease wise – Forecast for Zoster (Shingles) Number (Million), 2022 – 2027
Figure-31: Disease wise – MMR Number (Million), 2016 – 2021
Figure-32: Disease wise – Forecast for MMR Number (Million), 2022 – 2027
Figure-33: Disease wise – Pneumococcal Number (Million), 2016 – 2021
Figure-34: Disease wise – Forecast for Pneumococcal Number (Million), 2022 – 2027
Figure-35: Disease wise – Meningococcal Number (Million), 2016 – 2021
Figure-36: Disease wise – Forecast for Meningococcal Number (Million), 2022 – 2027
Figure-37: Disease wise – Hepatitis Number (Million), 2016 – 2021
Figure-38: Disease wise – Forecast for Hepatitis Number (Million), 2022 – 2027
Figure-39: Disease wise – TdaP Number (Million), 2016 – 2021
Figure-40: Disease wise – Forecast for TdaP Number (Million), 2022 – 2027
Figure-41: Disease wise – Varicella Number (Million), 2016 – 2021
Figure-42: Disease wise – Forecast for Varicella Number (Million), 2022 – 2027
Figure-43: GlaxoSmithKline, plc.’s Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-44: GlaxoSmithKline, plc.’s Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-45: Merck & Co. Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-46: Merck & Co. Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-47: Sanofi Pasteur’s Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-48: Sanofi Pasteur’s Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-49: Pfizer, Inc.’s Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-50: Pfizer, Inc.’s Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-51: Thoracic Aortic Aneurysm (TAA)CSL Limited sales – Global Revenue (Million US$), 2016 – 2021
Figure-52: Thoracic Aortic Aneurysm (TAA)CSL Limited sales – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Adult Vaccines Market Share by Vaccine Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Adult Vaccines Market Share by Vaccine Type (Percent), 2022 – 2027
Table-03: Global – Adult Vaccines Population Share by Vaccine Type (Percent), 2016 – 2021
Table-04: Global – Forecast for Adult Vaccines Population Share by Vaccine Type (Percent), 2022 – 2027